1909 |
ENDOTHELIN RECEPTOR TYPE A |
EDNRA |
ET-A |
ETA |
ETA-R |
ETAR |
ETRA |
MFDA |
hET-AR |
131243 |
3179 |
ENSG00000151617 |
OTTHUMG00000161354 |
ENDOTHELIN-1 RECEPTOR |
ENDOTHELIN A RECEPTOR |
P25101 |
EDNRA_HUMAN |
ENDOTHELIN-1 RECEPTOR PRECURSOR (ENDOTHELIN A RECEPTOR) (ET-A) (HET- AR) (ETA-R). [SOURCE:UNIPROT/SWISSPROT;ACC:P25101] |
T23499 |
Interpro Type | Family |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | 7TM_GPCR_Rhodpsn |
Human Readable Name | G PROTEIN COUPLED RECEPTOR |
Uniprot Status | Swiss-Prot |
Interpro Acc | IPR000276 |
Interpro Name | GPCR, rhodopsin-like, 7TM |
Uniprot Evidence | 1: Evidence at protein level |
Target Subclass | GPCR |
Target Subclass | Rhodopsin |
Transmembrane Helix Count | 7 |
Target Main Class | Receptors |
Target Class | Receptors |
Gene Biotype | PROTEIN_CODING |
G PROTEIN COUPLED RECEPTOR |
DRUGGABLE GENOME |
antagonist (inhibitory) |
Trial Name | clazosentan, AXV-343434,Pivlaz |
Novel drug target | Established target |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Trial Name | YM-598 |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Direct Interaction | yes |
Notes |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Endothelin receptor, ET-A/ET-B antagonist |
Trial Name | macitentan , ACT-064992 |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor, ET-A/ET-B antagonist |
Direct Interaction | yes |
Trial Name | Letairis |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Trial Name | darusentan |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | atrasentan, ABT-627,Xinlay |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor, ET-A/ET-B antagonist |
Direct Interaction | yes |
Trial Name | Tracleer |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Direct Interaction | yes |
Trial Name | avosentan, SPP 301 |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
antagonist (inhibitory) |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Endothelin receptor ET-A antagonist |
n/a |
Trial Name | SPI-1620 |
Novel drug target | Established target |
EDNRA | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
1909 | Entrez Gene Id |
P25101 | Uniprot Accession |
EDNRA_HUMAN | Uniprot Id |
Interpro Type | Family |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | 7TM_GPCR_Rhodpsn |
G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME |
EDNRA | Gene Symbol |
EDNRA_HUMAN | Uniprot Id |
ENSG00000151617 | Ensembl Gene Id |
Target Subclass | GPCR |
Target Subclass | Rhodopsin |
Transmembrane Helix Count | 7 |
EDNRA | Gene Symbol |
Target Class | Receptors |
Target Subclass | GPCR |
Target Subclass | Rhodopsin |
EDNRA | Display Id |
ENDOTHELIN-1 RECEPTOR PRECURSOR (ENDOTHELIN A RECEPTOR) (ET-A) (HET- AR) (ETA-R). [SOURCE:UNIPROT/SWISSPROT;ACC:P25101] | Description |
ENSG00000151617 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
EDNRA | TTD Gene Abbreviation |
T23499 | TTD Target ID |
ETAR | Gene Symbol |
ENSG00000151617 | Gene Symbol |
EDNRA | Ensembl Id |
DRUGGABLE GENOME |
ETRA | GENE_SYMBOL |
EDNRA | GENE_SYMBOL |
Endothelin-1 receptor | UNIPROT |
1909 | Gene ID |
ET-A | dGene Synonym |
ETA | dGene Synonym |
G PROTEIN COUPLED RECEPTOR |